Immune checkpoint inhibitor therapy-induced autoimmune polyendocrine syndrome type II and Crohn’s disease: A case report

BACKGROUND: The development of immune checkpoint inhibitors (ICIs) has heralded a new era in cancer treatment, enabling the possibility of long-term survival in patients with metastatic disease. Unfortunately, ICIs are increasingly implicated in the development of autoimmune diseases. CASE SUMMARY:...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Mei-Juan, Xu, Yan, Wang, Wen-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237137/
https://www.ncbi.nlm.nih.gov/pubmed/37274046
http://dx.doi.org/10.12998/wjcc.v11.i14.3267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237137/
https://www.ncbi.nlm.nih.gov/pubmed/37274046
http://dx.doi.org/10.12998/wjcc.v11.i14.3267

Ejemplares similares